2013
DOI: 10.1016/j.neuint.2012.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
95
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 147 publications
(97 citation statements)
references
References 56 publications
2
95
0
Order By: Relevance
“…There is speculation that iron plays a large role in the pathophysiology of some common neurodegenerative disorders like Alzheimer's disease (AD), Parkinson's disease, Huntington's disease, and Neurochem Res amyotrophic lateral sclerosis [49]. Iron overload in rats enhances reactive oxygen species (ROS) [50], in brain regions such as the cerebral cortex and the hippocampus, areas known to be affected in AD [51]. Importantly, our previous studies exhibited that iron induced cholinergic deficits in the cerebral cortex in rats are protected by simultaneous treatment with naringenin [20].…”
Section: Discussionmentioning
confidence: 99%
“…There is speculation that iron plays a large role in the pathophysiology of some common neurodegenerative disorders like Alzheimer's disease (AD), Parkinson's disease, Huntington's disease, and Neurochem Res amyotrophic lateral sclerosis [49]. Iron overload in rats enhances reactive oxygen species (ROS) [50], in brain regions such as the cerebral cortex and the hippocampus, areas known to be affected in AD [51]. Importantly, our previous studies exhibited that iron induced cholinergic deficits in the cerebral cortex in rats are protected by simultaneous treatment with naringenin [20].…”
Section: Discussionmentioning
confidence: 99%
“…In AD, increased iron co-localizes with insoluble tau tangles and facilitates the loss of soluble tau, further perturbating tau-mediate APP shuttling and ferroportin iron export 141,153 . The usage of iron chelators highlights this relationship as they decrease the phosphorylation of tau and its aggregation 45 . The loss of soluble tau prevents the tau stabilization of microtubules, altering molecular transport important for neurotransmission, synapse stability, and cellular health 158 .…”
Section: Neuronmentioning
confidence: 99%
“…Deferoxamine (DFO), a ferric iron chelator used to treat iron overload, has been shown to decrease tau phosphorylation, slow down amyloidogenesis, and improve behavioral impairment in an Alzheimer’s mouse and rabbit models 45–48 . DFO also improves behavioral performance in AD patients after a 24 month administration period 49 .…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, iron interacts with hyperphosphorylated tau, an interaction that contributes to the formation of neurofibrillary tangles (Guo et al, 2013;Smith et al, 1997). Treatment of Fe 3+ -paired helical filament (PHF) aggregates from AD brains with the reducing agent β-mercaptoethanol results in solubilization of both reduced iron and PHFs, indicating that PHFs in association with Fe 3+ constitute the insoluble pool of PHFs (Yamamoto et al, 2002).…”
Section: Mitochondrial Dysfunction and Iron Accumulation In Admentioning
confidence: 99%